The Chief Executive Officer at AstraZeneca, Pascal Soriot, says the delivery of first doses of the AstraZeneca vaccine to Ghana marks a major step forward in changing the course of the COVID-19 pandemic globally.
“This delivery is the first of many shipments of the AstraZeneca vaccine expected over the coming weeks and months via COVAX that will take us closer to ensuring broad and equitable access,” he said in a statement issued on February 24, 2021.
Ghana on Wednesday, February 24, 2021, took delivery of 600,000 doses of the AstraZeneca COVID-19 vaccine made by the Serum Institute of India (Covishield).
Ghana became the first country to receive the vaccine from the COVID-19 Vaccine Global Access Facility (COVAX), which has 92 beneficiary countries signed on to it, the World Health Organisation (WHO) said.
The AstraZeneca boss said “This delivery is the first of many shipments of the AstraZeneca vaccine expected over the coming weeks and months via COVAX that will take us closer to ensuring broad and equitable access.”
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.